Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

A Páscoa chegou ao fim, mas a dúvida sempre fica: chocolate dá espinha?


News provided by

Galderma

Apr 28, 2023, 11:37 ET

Share this article

Share toX

Share this article

Share toX

SÃO PAULO, 28 de abril de 2023 /PRNewswire/ -- A Páscoa passou e não teve como resistir àquele chocolatinho. Afinal, o que não faltaram foram opções para todos os gostos. Uma verdadeira tentação para os chocólatras de plantão.

E para quem já sofre com o excesso de oleosidade da pele, toda preocupação é pouca nestas sazonalidades. Mas, afinal, chocolate dá espinhas? Dermotivin® Benzac traz algumas informações para desmistificar os mistérios sobre esse assunto.

Continue Reading

A verdade é que não existe nenhuma comprovação científica de que o chocolate tem alguma relação com o aparecimento de espinhas. Segundo a Sociedade Brasileira de Dermatologia (SBD), o excesso de doces e alimentos gordurosos é o que pode causar a acne, já que ajuda no aumento da oleosidade da pele e agrava a predisposição de pessoas com a pele acneica¹. Ou seja, a ingestão do chocolate por si só não é o problema.

Na adolescência esse problema fica ainda mais aparente: os hormônios estimulam o funcionamento das glândulas sebáceas e com consumo excessivo de açúcares, há também a produção exagerada de sebo, que entope os canais de saída da pele e forma os cravos e espinhas². 

Por esse motivo, a dica boa para ser compartilhada é: pode comer o seu chocolate favorito, mas não exagere no consumo de açúcar e nem abra mão da sua rotina de skincare. E a linha Oil Control de Dermotivin® Benzac pode ser uma grande aliada na sua rotina Pós-Páscoa, com produtos que atendem as necessidades das peles mais oleosas e com tendência a acne.

O sabonete líquido de Dermotivin® Benzac Oil Control proporciona limpeza profunda para pele oleosa, promove efeito adstringente e ação refrescante na pele, deixando uma sensação de frescor. É super prático para o dia a dia3. 

Para utilização, aplique sobre o rosto e pescoço umedecidos em suaves movimentos circulares. Enxágue por completo. Use duas vezes ao dia ou conforme orientação do seu dermatologista.

O Hidratante Matificante de Dermotivin® Benzac Oil Control auxilia na redução e controle do brilho da pele por 12 horas4, enquanto promove a hidratação que esse tipo de pele pede. Ele pode ser usado como primer antes da make do dia e ainda proporciona um efeito matificante5.

 Para melhor usabilidade, aplicar generosamente o produto na pele limpa duas vezes ao dia (manhã e noite) ou conforme orientação do seu dermatologista.

Já o gel de tratamento antiacne Dermotivin Benzac⁵ age por meio de tripla ação: antibacteriana6 que mata 94% das bactérias que causam acne; anti-inflamatória7 que reduz a inflamação, diminuindo as espinhas; e comedolítica8 que desobstrui os poros e reduz o número de cravos. Dermotivin disponibiliza géis de tratamento nas versões 5% e 10%9.

Para proteção adequada, basta aplicar uma fina camada de gel nas áreas afetadas duas vezes ao dia. É recomendável ainda o uso de bloqueador solar durante o dia.

Vale lembrar que é importante a consulta com um dermatologista para manter uma rotina saudável de cuidados com a pele. Os produtos Dermotivin Benzac estão disponíveis nas principais drogarias de todo o país como na Rede Panvel.

¹Sociedade Brasileira de Dermatologia Seção RS. Artigo acessado em 17 de março de 2023. Link

²Sociedade Brasileira de Dermatologia. Artigo acessado em 17 de março de 2023. Link

3Data on file: Per-E-EP-29574-03-09-11 Líquido

4RD.12.SPR.110634 ESTUDO CLÍNICO DO POTENCIAL ACNEGÊNICO E COMEDOGÊNICO E DA ACEITABILIDADE CUTÂNEA E OCULAR DE UM PRODUTO COSMÉTICO E SUA EFICÁCIA NO CONTROLE DO BRILHO DA PELE E REDUÇÃO DE POROS DILATADOS

5Fórmula

6A linha DERMOTIVIN BENZAC é composta também pelos géis de tratamento antiacne DERMOTIVIN BENZAC 5% e DERMOTIVIN BENZAC 10%, que possuem as seguintes minibulas: 

DERMOTIVIN BENZAC 5% (peróxido de benzoíla) é indicado para o tratamento da acne. SE PERSISTIREM OS SINTOMAS, O MÉDICO DEVERÁ SER CONSULTADO. DERMOTIVIN® 5% É UM MEDICAMENTO. SEU USO PODE TRAZER RISCOS. PROCURE O MÉDICO E O FARMACÊUTICO. LEIA A BULA (Rotulagem). MEDICAMENTO NOTIFICADO conforme RDC n° 576/2021. 

DERMOTIVIN BENZAC 10% (peróxido de benzoíla) é indicado para o tratamento da acne. SE PERSISTIREM OS SINTOMAS, O MÉDICO DEVERÁ SER CONSULTADO. DERMOTIVIN® 10% É UM MEDICAMENTO. SEU USO PODE TRAZER RISCOS. PROCURE O MÉDICO E O FARMACÊUTICO. LEIA A BULA (Rotulagem). MEDICAMENTO NOTIFICADO conforme RDC n° 576/2021. 

7-8Kim MR, Kerrouche N. Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability. J Dermatolog Treat. 2018 Feb;29(1):49– 54. estudo patrocinado pela Galderma sobre nosso produto BPO 5% Gel. É um artigo sobre o nosso produto BPO 5% Gel

9Kim MR, Kerrouche N. Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability. J Dermatolog Treat. 2018 Feb;29(1):49– 54. estudo patrocinado pela Galderma sobre nosso produto BPO 5% Gel 

Sobre Galderma

A Galderma é a empresa líder na categoria exclusivamente dedicada à dermatologia, presente em aproximadamente 90 países. Fornecemos um portfólio inovador e baseado na ciência de marcas e serviços premium que abrangem todo o espectro do mercado de dermatologia em rápido crescimento, por meio de Estética Injetável, Dermocosméticos e Dermatologia Terapêutica. Desde nossa fundação em 1981, dedicamos nosso foco e paixão ao maior órgão do corpo humano – a pele – atendendo às necessidades individuais de consumidores e pacientes com resultados superiores em parceria com profissionais de saúde. Estamos avançando a dermatologia para cada história de pele, porque entendemos que a pele em que estamos molda nossas histórias de vida.

Para saber mais acesse: Link e Link 

Foto - https://mma.prnewswire.com/media/2066087/Benzac.jpg

FONTE Galderma

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.